Goz Alhir

Vice President, Business Development, Sales, & Operations at Vanigent

Speaker

Goz Alhir has spent 30+ years building commercial organizations in precision oncology, molecular diagnostics, and specialty therapeutics at Vanigent BioPharm, Caris Life Sciences, Strata Oncology, Adaptive Biotechnologies, NanoString, Onyx, and Eli Lilly. He built Adaptive's commercial team from zero to a first-to-market MRD launch, generated $315M in revenue while leading 250+ people at Caris, and shaped the company's pricing strategy as part of Onyx's executive pricing committee. Now, as VP of Business Development, Sales & Operations at Vanigent, he's focused on where AI genuinely changes commercial execution—not content, but targeting, engagement, and field performance.